Adimab
Developer of yeast-based therapeutic human antibodies designed to improve the quality of the therapeutic lead.
Drug Discovery
📍 Lebanon, NH
Founded 2007
Current Valuation
$1.1B
as of 2015-Q1
UNICORN
Developer of yeast-based therapeutic human antibodies designed to improve the quality of the therapeutic lead.
Company Profile
Last Round
Later Stage VC — $100M (Jan 2015)
Fundraising Status
Later Stage VC · $100M · 11y 5mo ago
privateTotal raised $143M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Later Stage VC | $100M | Jan 2015 | — | $1.1B |
BiotechnologyCollaborationHealth Care
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2015-Q1. Refreshed quarterly.